期刊文献+

体内Pig-a基因突变实验评估纳米氧化锌致突变性

Evaluation of mutagenicity of zinc oxide nanoparticles by Pig-a mutation assay in vivo
原文传递
导出
摘要 【目的】利用体内Pig⁃a基因突变实验方法,检测纳米氧化锌(ZnO NPs)颗粒对大鼠遗传毒性的作用。【方法】结合28 d经口毒性试验,设14、70、350 mg‧kg^(−1) ZnO NPs(纳米尺度分散状态最大浓度)3个剂量组、常规ZnO组(350 mg‧kg^(−1) ZnO)、阳性对照组(40 mg‧kg^(−1) N⁃亚硝基⁃N⁃乙基脲)和溶剂对照组(0 mg‧kg^(−1) ZnO NPs),每组各10只大鼠经口灌胃28 d,记录并观察体重变化。在给药0、15、28 d和恢复观察期28 d取各组大鼠尾静脉血200µL,用APC mouse anti⁃rat erythroid cells及FITC mouse anti⁃rat CD59抗体进行标记后,使用流式细胞仪收集各样本1×10^(6)个红细胞信息,计算其中外周血红细胞CD59缺失突变发生率。【结果】与溶剂对照组比较,在灌胃15 d后,350 mg‧kg^(−1) ZnO NPs组、阳性对照组大鼠外周血红细胞CD59缺失突变发生率均升高,差异均有统计学意义(均P<0.01);在灌胃28 d后,70 mg‧kg^(−1) ZnO NPs组、350 mg‧kg^(−1) ZnO NPs组和阳性对照组大鼠红细胞CD59缺失突变发生率均升高,且呈时⁃效和量⁃效关系;在停止灌胃28 d后,除阳性对照组外,其余各组大鼠外周血红细胞CD59缺失发生率与溶剂对照组比较差异均无统计学意义(均P>0.05)。【结论】70、350 mg‧kg^(−1) ZnO NPs会提高大鼠外周血Pig⁃a基因突变率。 [Objective]The genotoxicity of zinc oxide nanoparticles(ZnO NPs)in rats was determined by Pig⁃a mutation assay in vivo.[Methods]Combined with 28-day oral toxicity test,male SD rats were given ZnO NPs by oral administration for 28 days,at doses of 0,14,70 and 350 mg‧kg^(−1)(maximum concentration of nanoscale dispersion state).Rats in control groups received 350 mg‧kg^(−1) of normal size ZnO,40 mg‧kg^(−1) N-ethyl-N⁃nitrosourea(ENU)or 0 mg·kg^(−1) ZnO NPs(solvent control group)Changes of body weight were recorded.At 0,15,28 d and 28 d of recovery observation period,200µL of tail venous blood was collected from each group,which was labeled by APC mouse anti-rat erythroid cells and FITC mouse anti-rat CD59.The information of 1×10^(6) red blood cells(RBC)from each sample were collected by flow cytometry,and the mutation rate of RBC^(CD59-)was calculated.[Results]Compared with the solvent control group,after 15 days of intragastric administration,the mutation rate of RBC^(CD59-) in peripheral blood of in 350 mg‧kg^(−1) ZnO NPs group and 40 mg‧kg^(−1) ENU group was significantly increased while that of in 70 mg‧kg^(−1) ZnO NPs group was also significantly increased after 28 days of intragastric administration.with timeresponse and dose-response relationship.All groups except 40 mg‧kg^(−1) ENU group showed no significant difference in the mutation rate of RBC^(CD59-) in peripheral blood in comparison with the solvent control group after 28-days recovery observation.[Conclusion]70 and 350 mg‧kg^(−1) ZnO NPs can increase the mutation rate of Pig⁃a gene in peripheral blood of SD rats.
作者 成雪晴 杨隽 刘玺 邵乃敏 洪新宇 CHENG Xueqing;YANG Jun;LIU Xi;SHAO Naimin;HONG Xinyu(Chemical Toxicity Testing Institute,Department of Animal Toxicology Testing and Evaluation,Shanghai Municipal Center for Disease Control and Prevention,Shanghai 200336,China)
出处 《上海预防医学》 CAS 2022年第6期563-567,共5页 Shanghai Journal of Preventive Medicine
基金 上海市卫生和计划生育委员会科研课题(20174Y0070)。
关键词 纳米氧化锌 Pig⁃a基因突变实验 致突变性 时效关系 量效关系 zinc oxide nanoparticle Pig-a mutation assay mutagenicity time-response relationship dose-response relationship
  • 相关文献

参考文献6

二级参考文献50

  • 1BORM P J, ROBBINS D, HAUBOLD S, et al. The potential risks of nanomaterials: a review carried out for ECETOC[J]. Part Fibre Toxicol, 2006,3:11.
  • 2THOMAS K, AGUAR P, KAWASAKI H, et al. Research strategies for safety evaluation of nanomaterials, part Ⅷ: international efforts to develop risk-based safety evaluations for nanomaterials[ J ]. Toxicol Sci, 2006,92( 1 ) : 23.
  • 3SHIMADA A, KAWAMURA N, OKAJIMA M, et al. Translocation pathway of the intratracheally instilled ultrafine particles from the lung into the blood circulation in the mouse [ J]. Toxicol Pathol,2006,34(7) : 949.
  • 4ELDER A, OBERDORSTER G. Translocation and effects of ultrafine particles outside of the lung[J]. Clin Occup Environ Med,2006,5(4) :785.
  • 5JI J H, JUNG J H, KIM S S, et al. Twenty-eight-day inhalation toxicity study of silver nanoparticles in Sprague-Dawley rats[ J]. Inhal Toxicol, 2007,19: 857.
  • 6XIA T, KOVOCHICH M, BRANT J, et al. Comparision of the abilities of ambient and manufactured nanoparticles to induce celluar toxicity according to an oxidative stress paradigm[J]. Nano Lett,2006,6(8) : 1794.
  • 7ICH. Guidance on genotoxicity testing and data interpretation for pharmaceuticals intended for human use [EB/OL]. [2011-11-09]. http: //www.ich.org/products/guidelines/safety/article/ safety-guide|ines.htm|.
  • 8Lambert IB, Singer TM, Boucher SE, et al. Detailed review of transgenic rodent mutation assays [J]. Mutat Res, 2005, 590 (1/2/3): 1-280.
  • 9Dearfield KL, Veronique T, Cimino MC, et al. Follow-up actions from positive results of in vitro genetic toxicity testing [J]. Environ Mol Mutagen, 2011, 52 (3): 177-204.
  • 10Takeda J, Miyata T, Kawagoe K, et al. Deficiency of the GPI anchor caused by somatic mutation of Pig-a gene in paroxysmal nocturnal hemoglobinuria[J]. Cell, 1993, 73 (4): 703-711.

共引文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部